Min Lin

Title: Min Lin - Innovator in Synthetic Peptides

Introduction

Min Lin is a notable inventor based in Forest Park, IL (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic peptides that enhance tight junction permeability. His work has the potential to impact various medical treatments and improve patient outcomes.

Latest Patents

Min Lin holds 1 patent for his invention titled "Synthetic peptides that enhance tight junction permeability." This innovative patent provides novel peptides that facilitate the opening of mammalian tight junctions, known as tight junction agonists. The invention also outlines methods for treating diseases by administering a composition that includes a peptide tight junction agonist in combination with a therapeutically effective amount of an active agent.

Career Highlights

Min Lin is currently associated with Alba Therapeutics Corporation, where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions that address critical health challenges.

Collaborations

Min Lin collaborates with Amir P Tamiz, contributing to the collective expertise and innovation within their field. Their partnership enhances the potential for groundbreaking discoveries in biotechnology.

Conclusion

Min Lin's contributions to synthetic peptides and tight junction permeability represent a significant advancement in medical science. His innovative work at Alba Therapeutics Corporation showcases the importance of research and collaboration in developing effective treatments.